The global cardiac drug stent market size was USD 9.93 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. Rising prevalence of cardiovascular diseases, shifting preference toward minimally invasive therapeutic procedures, speedy evaluation, and approval of cardiac drug stents, along with incorporation of technological innovations in stent mechanism are major factors driving market revenue growth.
Government authorities have started hastening the process of evaluation and commercialization of cardiac drug stents, which is contributing to revenue growth of the market. On 26 July 2022 for instance, the innovative Pulsar-18 T3 peripheral self-expanding stent system from BIOTRONIK has been approved by the U.S. Food and Drug Administration (FDA) for a better insertion method during endovascular treatments, stated by the company. The business also disclosed that the device's complete U.S. commercial launch will start in early August.
Companies are also working on Research and Development (R&D) activities, forming mergers and acquisitions, partnership agreements, and forming other alliances, which is also contributing to revenue growth of the market. On 31 March 2021 for instance, the B. Braun SeQuent Please ReX drug coated PTCA balloon catheter, went through a faster FDA Investigational Device Exemption (IDE) clinical trial owing to a partnership between B. Braun Interventional Systems Inc. and Infraredx, a Nipro Company. With this statement, the B. Braun Group of Companies and Nipro Corporation, a Japanese company, would continue their extensive global partnership to enhance the treatment of coronary artery disease.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/814
Some of the major companies included in the global market report are Boston Scientific Corporation, Medtronic plc, B. Braun SE, Biotronik, Abbott, Terumo Corporation, Biosensors International Group, Ltd., MicroPort Scientific Corporation, Cook, and BD, among others.
On 24 August 2022, Medtronic announced launched of the latest drug-eluting coronary stent, the Onyx Frontier DES, after recent CE Mark clearance. The Resolute Onyx drug-eluting stent's initial performance and clinical data are built upon by the Onyx Frontier DES, which also offers a novel delivery mechanism. The DES uses the same best-in-class stent technology as Resolute Onyx DES and has an improved delivery mechanism to enhance acute performance in the most difficult situations and improve deliverability.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.reportsanddata.com/report-detail/cardiac-drug-stent-market
Here are some key highlights from the report:
The information you provided highlights the growth and developments in the cardiac drug stent market in Europe and Asia Pacific. Here are the key points:
Europe:
- Shifting preference towards minimally invasive procedures and government initiatives are driving revenue growth in the European market.
- The government of the UK has committed significant funds and investments to support health research and the manufacturing industry.
- Innovative product launches and advancements in existing product lines contribute to market growth.
- Translumina introduced VIVO ISAR, a Dual Drug Polymer-Free Coated Stent (DDCS), which combines safety and drug release kinetics.
Asia Pacific:
- The Asia Pacific region is expected to have the fastest revenue growth rate.
- The rising prevalence of chronic heart diseases and supportive government measures drive market growth.
- Advancements in stent technology, funds, and investments contribute to the expansion.
- Sino Medical Sciences Technology Inc. received marketing approval in China for their drug-eluting stent device, aimed at vascular stenosis treatment.
These developments indicate the growing demand for cardiac drug stents in both regions and the efforts made by governments and companies to support research, innovation, and manufacturing in the field.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.reportsanddata.com/request-customization-form/814
This report offers historical data and forecasts revenue growth at global, regional, and country levels, and provides an analysis of market trends in each segment, sub-segment, region, and country from 2019 to 2032. For the purpose of this report, Reports and Data has segmented the global cardiac drug stent market based on stent type, mode of delivery, biomaterial, end-use, and region:
Stent Type Outlook (Revenue, USD Billion; 2019-2032)
- Bioresorbable Stent
- Covered Stent
- Bare Metal Stent
- Drug-eluting Stent
- Others
Mode of Delivery Outlook (Revenue, USD Billion; 2019-2032)
- Balloon Expandable Sheet
- Self-expandable Sheet
Biomaterial Outlook (Revenue, USD Billion; 2019-2032)
- Natural Biomaterial
- Polymeric Biomaterial
- Metallic Biomaterial
End-use Outlook (Revenue, USD Billion; 2019-2032)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
- North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
Latin America
- Brazil
- Rest of LATAM
Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Israel
- Rest of MEA
Latest Research Reports Published by Reports and Data:
Blockchain in Healthcare Market by Type (Public, Private, Hybrid), Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing Management, Drug Supply Chain Management, Clinical Trials, Others), End-use (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), By Region Forecast to 2032
Hospital Equipment and Supplies Market By Product Type (Diagnostic Equipment, Patient Monitoring Equipment, Operating Room Equipment, Mobility Aids and Transportation Equipment, Sterilization Equipment, and Others), By End-use (Hospitals, Clinics, and Others), and By Region Forecast to 2032
Ankylosing Spondylitis (AS) Market By Type (Axial Spondyloarthritis, Non-Radiographic Axial Spondyloarthritis), By Treatment (Nonsteroidal Anti-Inflammatory Drugs, Biologics, Others), By End-User (Hospitals, Clinics, Others), and By Region Forecast to 2032
Influenza Diagnostics Market By Product Type [Rapid Influenza Diagnostic Tests (RIDT), Reverse Transcriptase Polymerase Chain Reaction (RT-PCR), Cell Culture, Immunofluorescence, and Others], By End-use (Hospitals, Clinical Laboratories, Research Laboratories, and Others), and By Region Forecast to 2032
Surgical Robot Market By Application (Orthopedics, Neurology, Urology, Gynecology, and Others), and By Region Forecast to 2032
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Trending Titles External Defibrillators Market| Atopic Dermatitis Market